Related Experiment Videos
[Treatment of chronic viral hepatitis with recombinant interferon-alfa]
1IV. sz. Egyetemi Belgyógyászati Klinika, Universität Wien, Austria.
Orvosi Hetilap
|July 5, 1992
Abstract:
The antiviral treatment with alfa-interferon is the first proven therapeutic possibility in chronic viral hepatitis. The rate of improvement to alfa-interferon ranges between 15-40% depending on the type of hepatitis. The optimal dose is 5 MU/day three times a week for 6 months in chronic hepatitis B, while 3 MU/day three times a week for months in chronic hepatitis C. Results of therapy can be improved using combination treatment in selected cases.